Evidence map›Paper›PMID 41456013›Full record

ArticleHarm reduction journal2025

Stability or versatility: transitions in fentanyl routes of administration.

Jeff Ondocsin, Sarah G Mars, Nicole Holm, Allison Schlosser, Jason Fessel, Amanda Cowan, Michael Duke, Daniel Ciccarone

Abstract read
In one paragraph

Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jeff Ondocsin *Family & Community Medicine Department of Medicine, University of California, San Francisco, San Francisco, USA. jeffrey.ondocsin@ucsf.edu.
Sarah G Mars *Family & Community Medicine Department of Medicine, University of California, San Francisco, San Francisco, USA.
Nicole HolmFamily & Community Medicine Department of Medicine, University of California, San Francisco, San Francisco, USA.
Allison SchlosserSociology and Anthropology Department, University of Nebraska Omaha, Omaha, USA.
Jason FesselFamily & Community Medicine Department of Medicine, University of California, San Francisco, San Francisco, USA.
Amanda CowanCommunity Health Project Los Angeles, Los Angeles, USA.
Michael DukeFamily & Community Medicine Department of Medicine, University of California, San Francisco, San Francisco, USA.
Daniel CiccaroneFamily & Community Medicine Department of Medicine, University of California, San Francisco, San Francisco, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransitions in how people use drugs have long influenced drug use research and the policy landscape. In unregulated drug markets, route of administration (ROA) transitions from injecting opioids to non-injecting modes of use, sometimes called reverse transitions, are rare but have been documented historically, driven by local characteristics including social networks and drug market factors. National and local data find ROA transitions are on the rise in the US. We investigated patterns of ROA transitions, including personal and market-based motivations and perceived effects and health benefits.

methodsWe examined trends in San Francisco's drug market, including changes in substance use administration patterns and the forces motivating people who use drugs to adopt alternate or multimodal dosing strategies. We conducted 32 semi-structured qualitative interviews in 2022 using rapid assessment ethnography and observation to triangulate findings on ROA patterns and techniques among people using opioids.

resultsWe observed fluctuations in the relative availability of heroin and fentanyl which contributed to subsequent changes in ROA. Like other US locations, participants initiated fentanyl use as heroin availability diminished. Able to achieve comparable effects from fentanyl smoking relative to injection most participants indicated they had transitioned within the past several years, driven by venous access, overdose concerns and market characteristics. Transitions were graduated along a spectrum of stability, from frequent multimodal use to transitions in accord with recent patterns, notably featuring total cessation of injection. Others found combining smoking and injecting allowed greater flexibility, with smoking favored when in public, for convenience, considering sensitivity to non-injecting peers, or when seeking a milder experience enabling productivity or vigilance. Injecting was chosen for its faster effect, to avoid sharing drugs/equipment with others and especially for polysubstance combinations. A small subset of participants indicated that smoking was not a durable transition for them, necessitating a return to injection.

conclusionsThe stability of ROA transitions and their health impacts remain in flux amidst widespread uptake of smoking fentanyl. Smoking supply provision and harm reduction organizations are facing notable headwinds but continue to be essential for providing people control over their health and embodied and social experiences.

Indexed as

Analgesics, OpioidFentanylOpioid-Related DisordersSubstance Abuse, IntravenousAdultDrug Administration RoutesFemaleHeroinHumansMaleMiddle AgedMotivationQualitative ResearchSan FranciscoYoung AdultAnalgesics, OpioidFentanylHeroinFentanylHarm reduction servicesInjectionOpioidsOverdoseRoute of administrationSmokingUS

Identifiers

PMID41456013
PMCPMC12860034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.